Transcriptional repression of NFKBIA triggers constitutive IKK‐ and proteasome‐independent p65/RelA activation in senescence
Open Access
- 18 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in The EMBO Journal
- Vol. 40 (6), e104296
- https://doi.org/10.15252/embj.2019104296
Abstract
The IκB kinase (IKK)‐NF‐κB pathway is activated as part of the DNA damage response and controls both inflammation and resistance to apoptosis. How these distinct functions are achieved remained unknown. We demonstrate here that DNA double‐strand breaks elicit two subsequent phases of NF‐κB activation in vivo and in vitro, which are mechanistically and functionally distinct. RNA‐sequencing reveals that the first‐phase controls anti‐apoptotic gene expression, while the second drives expression of senescence‐associated secretory phenotype (SASP) genes. The rapidly activated first phase is driven by the ATM‐PARP1‐TRAF6‐IKK cascade, which triggers proteasomal destruction of inhibitory IκBα, and is terminated through IκBα re‐expression from the NFKBIA gene. The second phase, which is activated days later in senescent cells, is on the other hand independent of IKK and the proteasome. An altered phosphorylation status of NF‐κB family member p65/RelA, in part mediated by GSK3β, results in transcriptional silencing of NFKBIA and IKK‐independent, constitutive activation of NF‐κB in senescence. Collectively, our study reveals a novel physiological mechanism of NF‐κB activation with important implications for genotoxic cancer treatment.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (SCHE277/8‐1)
- Helmholtz Association
- Deutsche Krebshilfe (110678)
This publication has 53 references indexed in Scilit:
- Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescenceCell Cycle, 2012
- NF-κB, the first quarter-century: remarkable progress and outstanding questionsGenes & Development, 2012
- Opposing roles of NF-κB in anti-cancer treatment outcome unveiled by cross-species investigationsGenes & Development, 2011
- Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivityGenes & Development, 2011
- Spatial Coupling of mTOR and Autophagy Augments Secretory PhenotypesScience, 2011
- p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotypeThe EMBO Journal, 2011
- Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretionNature, 2009
- Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor SuppressorPLoS Biology, 2008
- Downregulation of Wnt Signaling Is a Trigger for Formation of Facultative Heterochromatin and Onset of Cell Senescence in Primary Human CellsMolecular Cell, 2007
- BCL2 family in DNA damage and cell cycle controlCell Death & Differentiation, 2006